Cr(V)
involvement in the toxicity pathway of testicular damage
M. L. Pereira1, T.
M. Santos2, R. Pires das Neves1, F. G. Costa3,
J. Pedrosa de Jesus2
1Department of Biology;
2Department of Chemistry, University of Aveiro, 3810-193, Aveiro,
Portugal
3 Histology and Anatomic Pathology
Section, Faculty of Veterinary Medicine, Technical University of Lisbon,
Portugal
Asian
J Androl 2002
Jun;
4: 153-155
Keywords:
Cr(V); blood-testis barrier; integrity; spermatogenesis; horseradish peroxidase
Abstract
Aim:
The functional integrity of the blood-testis barrier (BTB) in male mice
exposed to Cr(V) was studied in order to clarify the mechanism underlying
testicular injury. Methods: Adult male mice were subcutaneously
injected repeated doses of 8.02 mmol
(0.5 mL) of Cr/mouse.day for 5 days. Animals receiving a similar
volume of bis(hydroxyethyl)-aminotris(hydroxymethyl)methane buffer (BT)
were used as controls. The animals were sacrificed on day 6 and small
fragments of seminiferous tubules, approximately 8-10 mm length, were
incised and sutured at both ends. They were exposed in vitro to
horseradish peroxidase-containing culture medium for 10 minutes. Tissues
were then fixed and processed for ultrastructural studies. Results:
Controls and Cr(V)-treated group resulted in the uptake of the tracer
by Sertoli cells. However, the major finding consisted in the permeability
of the BTB only in the Cr(V)-group, as evidenced by the presence of the
tracer within the junctions between the neighbouring Sertoli cells. Conclusion:
The BTB is disrupted in mice submitted to Cr(V). The permeability of the
BTB is a crucial feature to be investigated for the understanding of lesions
within the seminiferous tubule.
1 Introduction
Chromium(VI) is a well-recognized
environmental pollutant that may bring about adverse effects on both humans
and animals [1-2]. Additionally, there are potential hazards for industrial
workers [3-4]. Cr(V), generated as a metabolic intermediate from the intracellular
reduction of Cr(VI), is one of the major candidates for the carcinogenic
forms of the chromium compounds [5-7]. Recently, it was indicated that
Cr(VI) also produce undesirable effects on male reproductive physiology
[8-11]. We have just demonstrated that a Cr(V) complex, [CrV-BT]2-,
was able to induce testicular lesions in the mouse [12]. To our knowledge,
no other references are so far available in the literature concerning
the effects of Cr(V) on male reproduction.
The present work describes for the first
time the effects of the new Cr(V) compound on the functional integrity
of the blood-testis barrier (BTB), which plays a significant role on spermatogenesis.
2 Materials and methods
2.1 Animals
Experiments were conducted
in 60 days old male Charles River mice (30 g) kept under laboratory conditions
for small rodents (12h light/12h dark cycle; 60 % humidity; 222).
Food and water were available ad libitum. Twenty animals were randomly
divided in two groups, the Cr(V)-treated and the controls of 10 animals
each.
2.2 Preparation of chromium(V)
compound
[CrV-BT]2-
[BT is bis(hydroxyethyl)-aminotris(hydroxymethyl)methane buffer] was obtained
in situ in aqueous solution, by full ligand substitution (30 min)
from the precursor complex Na[CrVO(ehba)2], sodium
bis(2-ethyl-2-hydroxybutanoato)oxochromate(V) [6,13].
2.3 Treatment of animals
Mice of the Treated group
were subcutaneously administered 8.02 mmol
(0.5 mL) of Cr/mouse.day for 5 days [14]. The Control group
was injected with a similar volume of a physiological solution (BT) for
the same period of time. Mice were sacrificed on day 6 under ether anaesthesia
and the testis was removed.
2.4 In
vitro incubation with horseradish peroxidase
The seminiferous tubules
were isolated from the control and the treated mice and around sixty small
fragments of the tubules (each about 8-10 cm in length) were incised and
sutured at both ends with a cotton thread. Tubules were then incubated
in vitro for 10 min at 37 with
Eagle's medium
(Biomrieux) containing 5 mg/mL of horseradish peroxidase (HRP Type II;
Sigma) supplemented with 10 % fetal calf serum (GIBCO) as described [15].
2.5 Ultrastructural
studies
The tubular fragments were then fixed with
2.5 % glutaraldehyde in 0.1 M caccodilate buffer and placed for 45 min
in 10 mL of Tris buffer solution with 5 mg of diaminobenzidine and 0.1
mL of 1 % H2O2. Tissues were postfixed in 2 % buffered
osmium tetroxide, dehydrated and embedded in Epon 812. Thin sections prepared
with a diamond knife were double stained with uranyl acetate and lead
citrate. At least 2 or 3 sections were made in each tubule. Observations
were conducted using a Hitachi transmission electron microscope.
3 Results
The seminiferous epithelium
fragments of the Cr(V)-injected mice, in particular the Sertoli cells,
were able to uptake the HRP added to the culture medium. The uptake of
this macromolecule was accomplished by small vesicles, which moved into
the intercellular space where the releasing of the tracer took place.
HRP also permeated the intercellular junctions between the neighbouring
Sertoli cells, reaching the adlumenal compartment of the seminiferous
tubules (Figure 1). The intercellular
spaces around the Sertoli cells were widened, and the tight contacts with
the neighbouring cells were disrupted in all the Cr(V)-treated animals.
In the controls, the Sertoli cells were also able to uptake the tracer,
but the BTB was not damaged (inset).
Figure
1. Ultrastructural aspect of the intercellular junctions between Sertoli
cells in Cr(V)-injected mouse filled with the tracer (arrows); S -Sertoli
cell; V -Vacuoles; inset -The impenetrable inter-Sertoli cell tight junctions
of a control mouse (arrows). Bar = 1 mm.
4 Discussion
This work was conducted
to shed light on the possible mechanisms of Cr(V)-induced testis injury
and demonstrated for the first time that the BTB is the potential target
site. Consequently, exfoliation of immature germ cells within the lumen
of the seminiferous tubules, as described in our previous paper [12],
may result from the failure of the BTB integrity. It is well known that
Sertoli cells provide, select and/or transport from the systemic circulation
the required molecules for germ cell development. Thus, substances from
the interstitial tissue must pass through or between Sertoli cells in
order to reach the adlumenal compartment of the seminiferous tubules.
However, the presence of tight junctions between these somatic cells,
prevent most substances from reaching the adluminal compartment, unless
they pass through the Sertoli cell cytoplasm [16,17]. These findings support
the conclusion that Cr(V) is implicated in the bio-toxic pathway of testis
injury, by disrupting the BTB.
Other investigations have
already demonstrated damages on male reproductive physiology induced by
Cr(VI) compounds [8-11]. Comparative studies between Cr(VI) and Cr(V)
effects on mice testis are in progress in our lab in order to obtain a
better understanding of the mecha-nisms underlying chromium in vivo
toxic effects.
Acknowledgements
This study was supported in part by grants
from the Research Centre on Inorganic Chemistry and Materials, from Aveiro
University (Portugal).
References
[1] IARC. Monographs on the
evaluation of carcinogenic risks to humans: chromium, nickel and welding.
International Agency for Research on Cancer (Lyon) 1990; 49: Chap. 3.
[2] Dayan AD, Paine AJ. Mechanisms of chromium toxicity, carcinogenicity
and allergenicity: review of the literature from 1985 to 2000. Hum Exp
Toxicol 2001; 20: 439-51.
[3] De Flora S. Threshold mechanisms and site specificity in chromium(VI)
carcinogenesis. Carcinogenesis 2000; 21: 533-41.
[4] Gibb HJ, Lees PS, Pinsky PF, Rooney BC. Lung cancer among workers
in chromium chemical production. Am J Ind Med 2000; 38: 115-26.
[5] Dillon CT, Lay PA, Bonin AM, Cholewa M, Legge GJ, Collins TJ et
al. Permeability, cytotoxicity, and genotoxicity of chromium (V) and
chromium (VI) complexes in V79 Chinese hamster lung cells. Chem Res Toxicol
1998; 11: 119-29.
[6] Codd R, Dillon CT, Levina A, Lay PA. Studies on the genotoxicity of
chromium: from the test tube to the cell. Coord Chem Rev 2001: 216-17,
537-82.
[7] Liu KJ, Shi X. In vivo reduction of chromium(VI) and its related
free radical generation. Mol Cell Biochem 2001; 222: 41-7.
[8] Sutherland JE, Zhitkovich A, Kluz T, Costa M. Rats retain chromium
in testis following chronic ingestion of drinking water containing hexavalent
chromium. Biol Trace Elem Res 2000; 74: 41-53.
[9] Chowdhuri DK, Narayan R, Saxena DK. Effect of lead and chromium on
nuclei acid and protein synthesis during sperm-zona binding in mice. Toxicol
in vitro 2001; 15: 605-13.
[10] Li H, Chen Q, Li S, Yao W, Li L, Shi X, et al. Effect of Cr(VI)
exposure on sperm quality: human and animal studies. Ann Occu Hyg 2001;
45: 505-11.
[11] Veeramachaneni DN, Palmer JS, Amann RP. Long-term effects on male
reproduction of early exposure to common chemical contaminants in drinking
water. Hum Reprod 2001; 16: 979-87.
[12] Pereira ML, Pires das Neves R, Santos TM, Pedrosa de Jesus J. Morphological
alterations of male reproductive organs in mice exposed to Cr(V). Reprod
Toxicol (accepted).
[13] Fonkeng BS, Moghaddas S, Bose RN. Electron paramagnetic resonance,
kinetics of formation and decomposition studies of (bis(hydroxyethyl)amino-tris(hydroxymethyl)
methane)oxochromate(V): a model Cr(V) complex for DNA damage studies.
J Inorg Biochem 1998; 72: 163-71.
[14] Solis-Heredia MJ, Quintanilla-Vega B, Sierra-Santoyo A, Hernandez
JM, Brambila E, Cebrian ME, et al. Chromium increases pancreatic
metallothionein in the rat. Toxicol 2000; 142: 111-7.
[15] Pereira ML. Studies on the permeability of the blood-testis barrier
in stainless-steel-administered mice. Cell Biol Internat 1995; 7: 619-24.
[16] Grootegoed JA, Siep M, Baarends WM. Molecular and cellular mechanisms
in spermatogenesis. Baillire's Clin
Endocrinol Metabol 2000; 14: 331-43.
[17] Creasy DM, Foster PM. Male reproductive system. In: Wanda M, Hascek-Hock
C, Rousseaux C, Wallig M, editors. Handbook of Toxicologic Pathology.
London: Academic Press; 2002. p 785-845.
home
Correspondence
to: Dr. M. L. Pereira,
Department of Biology, University of Aveiro, 3810-193, Aveiro, Portugal.
Fax: +351-234-426 408
E-mail: lpereira@bio.ua.pt
Received 2002-03-05
Accepted 2002-05-10
|